विवरण

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Today, millions of people are living with cancer or have had cancer. Cancer is the second leading cause of death in the United States. The global oncology drugs market is set to grow by US$ 77.33 के दौरान अरब 2021-2027, growing at a compound annual growth rate (सीएजीआर) का 7.4% पूर्वानुमान अवधि के दौरान, डेटा और एनालिटिक्स कंपनी स्ट्रैटेजीहेलिक्स के अनुसार. Rising geriatric population, surge in prevalence of cancer, early screening of the cancer, and increase in R&D spending from pharmaceutical & biotechnology companies are expected to boost the market growth in the coming years.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2017-2020 और पूर्वानुमान करें 2027 covering key market aspects like sales value for oncology drugs. The global oncology drugs market is segmented on the basis of drug class, indication, region. By drug class, it is categorized into chemotherapy, hormone therapy, immunotherapy, and targeted therapy. The immunotherapy segment held the largest market share in 2020. By indication, the oncology drugs market is divided into breast cancer, colorectal cancer, lung cancer, multiple myeloma, non-hodgkin’s lymphoma, prostate cancer, और दूसरे. The lung cancer segment accounted for the largest market share in 2020. Based on region, the oncology drugs market is divided into North America, एशिया प्रशांत, यूरोप, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol Myers Squibb (BMS), Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson (J&J), Merck KGaA, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. लिमिटेड.

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the oncology drugs market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

Drug class: chemotherapy, hormone therapy, immunotherapy, and targeted therapy
Indication: breast cancer, colorectal cancer, lung cancer, multiple myeloma, non-hodgkin’s lymphoma, prostate cancer, और दूसरे
क्षेत्र: उत्तरी अमेरिका, एशिया प्रशांत, यूरोप, and Rest of the World (ROW)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2017 को 2027

हितधारकों के लिए मुख्य लाभ

Get a comprehensive picture of the global oncology drugs market
विकास क्षेत्रों और निवेश के रुझानों को इंगित करें
Understand what the future of the global oncology drugs market looks like
प्रतिस्पर्धी परिदृश्य और अवसर की खिड़की की पहचान करें

विषयसूची

1. बाज़ार परिभाषा
2. अनुसंधान क्रियाविधि
3. बाजार के आंकड़े & आउटलुक
3.1 बाजार मूल्य
3.2 बाज़ार मूल्य का पूर्वानुमान
4. Oncology Drugs Market by Drug Class
4.1 Chemotherapy
4.2 Hormone Therapy
4.3 Immunotherapy
4.4 Targeted Therapy
5. Oncology Drugs Market by Indication
5.1 Breast Cancer
5.2 Colorectal Cancer
5.3 Lung Cancer
5.4 Multiple Myeloma
5.5 Non-Hodgkin’s Lymphoma
5.6 Prostate Cancer
5.7 अन्य
6. Oncology Drugs Market by Region
6.1 उत्तरी अमेरिका
6.2 एशिया प्रशांत
6.3 यूरोप
6.4 Rest Of The World (Row)
7. कंपनी प्रोफाइल
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 Astellas Pharma Inc.
7.4 AstraZeneca PLC
7.5 Bristol Myers Squibb (BMS)
7.6 Eli Lilly and Company
7.7 F. Hoffmann-La Roche AG
7.8 Johnson & Johnson (J&J)
7.9 Merck KGaA
7.10 Novartis AG
7.11 Pfizer Inc.
7.12 Takeda Pharmaceutical Co., लिमिटेड.
8. अनुबंध
8.1 स्ट्रेटेजीहेलिक्स के बारे में
8.2 अस्वीकरण